• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524INT
Device Problems Fluid/Blood Leak (1250); Malposition of Device (2616); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 11/17/2021
Event Type  Injury  
Event Description
It was reported that during left ventricular assist system (lvas) implant, the surgeon noted bleeding from the posterior part of the heart.After "re-connecting" the pump to the apical cuff the bleeding stopped.During implant the slide lock mechanism was well adapted, which was confirmed visually and by the standard "click-sound" by the field clinical specialist and proctor.The surgeon mentioned that the pump was rotated so that the outflow graft was standing more on top of the heart.No lvas alarms occurred during the event.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that during left ventricular assist system (lvas) implant, the surgeon noted bleeding from the posterior part of the heart.After "re-connecting" the pump to the apical cuff the bleeding stopped.During implant the slide lock mechanism was well adapted, which was confirmed visually and by the standard "click-sound" by the field clinical specialist and proctor.The surgeon mentioned that the pump was rotated so that the outflow graft was standing more on top of the heart.No lvas alarms occurred during the event.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the pump did not rotate more easily than expected and that the rest of the implant procedure was uneventful.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the reported apical cuff blood leak could not conclusively be determined through this evaluation; however, the account indicated that pump malposition was related to the surgeon¿s actions.It was reported that the surgeon noted bleeding from the posterior part of the heart.After "re-adapting" the pump to the apical cuff, bleeding stopped but the surgeon mentioned a rotation of the pump.During implant, the slide lock mechanism was well adapted confirmed visually and by standard "click-sound" by fcs and proctor.The pump did not rotate easier than expected, and the case was uneventful with no adverse events.There were no alarms, just bleeding behind the heart.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas), serial number: (b)(6).No product is available for investigation.The relevant sections of the device history records for (b)(6) was reviewed and showed no deviations from manufacturing or quality assurance specifications.The lvas kit shipped on 10sep2021.The heartmate 3 lvas instructions for use (ifu) is currently available.Section 1 ¿introduction¿ of this document lists bleeding as an adverse event that may be associated with the use of the heartmate 3 lvas.This document also provides information regarding anticoagulation, including recommended inr values, and the suggested anticoagulation modifications in the event that there is a risk of bleeding.Section 5 ¿surgical procedures¿ (under ¿preparing the ventricular apex site¿) contains information regarding the preparation of the ventricular apex site, including how to affix the apical cuff to the left ventricle.This section cautions that after the apical cuff has been sewn to the heart, the metal ring on the apical cuff should extend above the felt surface to allow proper engagement and locking with the slide lock of the heartmate 3 lvad.Ensure that apposition between the myocardial tissue and the cuff felt is continuous and sufficiently forceful to prevent bleeding.No further information was provided.The manufacturer is closing the file on this event.
 
Manufacturer Narrative
No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key12971076
MDR Text Key285537743
Report Number2916596-2021-07055
Device Sequence Number1
Product Code DSQ
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup,Followup
Report Date 04/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/13/2023
Device Model Number106524INT
Device Lot Number8094121
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/13/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberFA-Q124-HF-2
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient SexMale
Patient Weight98 KG
-
-